Daily FNArena News - Small Caps

New broker research reinforces the global opportunity for Life360 to become a dominant brand

Pharmaxis might be two clinical studies away from rehabilitation, reports Tim Boreham

Tim Boreham reports the world might soon be scrambling for helium, while also identifying three ASX-listed exposures

Superloop has acquired fellow student accommodation provider VostroNet, expected to deliver strategic synergies and expansion into new verticals

Brickworks, Australia’s biggest brickmaker, should be able to leverage its property segment for longer-term growth, but analysts have pointed to risk in short-term earnings amid a rising rate environment

Tim Boreham digs deep into the evolving world of cancer diagnostics, highlighting the newly named Inoviq Ltd

New research on Imdex points to a company in transition with less exposure to cyclical downturns for junior miners and exploration budgets

Brokers remain upbeat on the outlook for Ansarada Group following FY22 results, despite a softer near-term outlook

Although generating an adverse market reaction with its high expenditure guidance, analysts largely agree that overseas expansion will support Symbio’s growth longer-term

With exposure to resilient lottery markets, and ongoing growth in its digital penetration, analysts find Jumbo Interactive a sustainable option for investors seeking long-term growth